Studies have found that the blocking activity of the PI3K/Akt axis using inhibitors such as AZD5363 (Akt) or LY294002 (PI3K) results in enhanced tumor sensitivity to chemotherapy agents and ionizing radiation [46]. The gene discussed is AKT1; the disease is neoplasm.